Hongta Zhang

Title: The Innovative Contributions of Hongta Zhang

Introduction

Hongta Zhang is a notable inventor based in Hangzhou, China. He has made significant contributions to the field of biology, particularly in the development of heavy-chain antibodies. His work has implications for cancer treatment, showcasing the potential of targeted therapies.

Latest Patents

Hongta Zhang holds a patent for "Heavy-chain antibodies (VHHs) against claudin 18A2 and use thereof." This patent focuses on an anti-CLD18A2 VHH that can specifically bind to the epitope on CLD18A2. The complementarity determining region (CDR) of this VHH includes specific amino acid sequences that enhance its binding affinity and specificity. The corresponding fusion protein demonstrates a noticeable tumor suppression effect, highlighting its potential in therapeutic applications. He has 1 patent to his name.

Career Highlights

Throughout his career, Hongta Zhang has worked with Zhejiang Doer Biologics Co., Ltd. and Zhejiang Doer Biologics Corporation. His experience in these companies has allowed him to advance his research and contribute to innovative solutions in biotechnology.

Collaborations

Hongta Zhang has collaborated with notable colleagues such as Gaofeng Yao and Yali Lu. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Hongta Zhang's innovative work in the field of heavy-chain antibodies represents a significant advancement in targeted cancer therapies. His contributions continue to influence the landscape of biological research and therapeutic development.